Flagship Harbor Advisors, LLC Dexcom Inc Transaction History

Flagship Harbor Advisors, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 16, 2024	SELL	$114.22 - $140.1 $9,708 - $11,908	-85 Reduced 4.32%	1,881 $260,000
Q4 2023 Jan 10, 2024	BUY	$75.49 - $124.16 $148,413 - $244,098	1,966 New	1,966 $243,000
Q2 2023 Jul 11, 2023	SELL	$112.47 - $130.98 $1,462 - $1,702	-13 Reduced 0.7%	1,853 $238,000
Q1 2023 Apr 12, 2023	BUY	$104.0 - $122.92 $194,064 - $229,368	1,866 New	1,866 $216,000
Q1 2022 Apr 13, 2022	SELL	$94.08 - $130.2 $34,997 - $48,434	-372 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$129.87 - $162.82 $48,311 - $60,569	372 New	372 $200,000
Q4 2020 Feb 08, 2021	SELL	$78.0 - $104.5 $29,874 - $40,023	-383 Closed	0 $0
Q3 2020 Oct 13, 2020	BUY	$95.51 - $112.95 $20,821 - $24,623	218 Added 132.12%	383 $157,000
Q2 2020 Jul 31, 2020	BUY	$62.68 - $105.34 $3,447 - $5,793	55 Added 50.0%	165 $66,000
Q1 2020 May 12, 2020	BUY	$47.79 - $75.63 $3,584 - $5,672	75 Added 214.29%	110 $30,000
Q4 2019 Feb 14, 2020	BUY	$36.62 - $57.29 $805 - $1,260	22 Added 169.23%	35 $8,000
Q3 2019 Oct 22, 2019	BUY	$35.53 - $43.8 $461 - $569	13 New	13 $1,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $28.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Flagship Harbor Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Flagship Harbor Advisors, LLC with notifications on news.